Literature DB >> 32886528

Risk factors of geriatrics index of comorbidity and MDCT findings for predicting mortality in patients with acute mesenteric ischemia due to superior mesenteric artery thromboembolism.

Wei Tang1,2, Bo Jin1, Lian-Qin Kuang1, Jing Zhang1, Chun-Xue Li3, Yi Wang1.   

Abstract

OBJECTIVES: To identify risk factors of geriatrics index of comorbidity (GIC) and multidetector CT (MDCT) findings for predicting mortality in patients with acute mesenteric ischemia (AMI) due to superior mesenteric artery (SMA) thromboembolism.
METHODS: 33 patients with AMI due to SMA thromboembolism underwent abdominal MDCT and angiography. Patients' comorbidities and MDCT findings of ischemic bowel/mesenteric injuries, regions of SMA involved by thromboembolism, and degrees of SMA stenosis were retrospectively reviewed. The comorbidities were classified into 1-4 levels according to GIC. The association of MDCT signs and GIC classification with mortality were analyzed. Diagnostic performances of risk factors associated with mortality were evaluated by receiver operating characteristic (ROC) curve analyses.
RESULTS: Eighteen patients (54.5%) died during hospitalization or follow-up, including one patient with class 1, two patients with class 2, eight patients with class 3, and seven patients with class 4 according to GIC. Three risk factors significantly associated with mortality were identified, including pneumatosis and/or portomesenteric venous gas (PPMVG) (p = 0.017), four regions of SMA involved by thromboembolism (region I + II + III + IV) (p = 0.036), and class 3 + 4 of comorbidities (p = 0.001). The sensitivity and specificity of PPMVG, region I + II + III + IV, class 3 + 4 of comorbidities, and the three risk factors combined for diagnosing mortality were 33.3 and 100%, 27.8 and 100%, 83.3 and 73.3%, and 88.9 and 73.3%, respectively. The areas under the ROC curve (AUC) of the three risk factors combined (0.88) and class 3 + 4 of comorbidities (0.78) were larger than that of PPMVG (0.67) and region I + II + III + IV (0.64). The mortality rate rose from 15.4% in patients without risk factor to 66.7%, 100%, and 100% in patients with one, two, and three factors, respectively.
CONCLUSION: Three risk factors for mortality were identified in patients with AMI due to SMA thromboembolism, including PPMVG and four regions of SMA involved by thromboembolism on MDCT images, and class 3 + 4 of comorbidities. Close monitoring of these risk factors could possibly lower the mortality. ADVANCES IN KNOWLEDGE: Risk factors based on GIC and MDCT findings may be used to predict mortality in patients with AMI. Close monitoring of these risk factors could possibly lower the mortality.

Entities:  

Mesh:

Year:  2020        PMID: 32886528      PMCID: PMC7716002          DOI: 10.1259/bjr.20190605

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  34 in total

1.  Geriatrics index of comorbidity was the most accurate predictor of death in geriatric hospital among six comorbidity scores.

Authors:  Dina Zekry; Bernardo Hermont Loures Valle; Claudia Lardi; Christoph Graf; Jean-Pierre Michel; Gabriel Gold; Karl-Heinz Krause; François R Herrmann
Journal:  J Clin Epidemiol       Date:  2010-03-17       Impact factor: 6.437

2.  Evaluation of acute mesenteric ischemia: accuracy of biphasic mesenteric multi-detector CT angiography.

Authors:  A J Aschoff; G Stuber; B W Becker; M H K Hoffmann; B L Schmitz; H Schelzig; T Jaeckle
Journal:  Abdom Imaging       Date:  2009 May-Jun

3.  Assessment of Strangulation in Adhesive Small Bowel Obstruction on the Basis of Combined CT Findings: Implications for Clinical Care.

Authors:  Ingrid Millet; Delphine Boutot; Claire Faget; Emmanuelle Pages-Bouic; Nicolas Molinari; Marc Zins; Patrice Taourel
Journal:  Radiology       Date:  2017-07-31       Impact factor: 11.105

4.  Prognostic factors in patients with acute mesenteric ischemia.

Authors:  Doğan Yıldırım; Adnan Hut; Cihad Tatar; Turgut Dönmez; Muzaffer Akıncı; Mehmet Toptaş
Journal:  Turk J Surg       Date:  2017-06-01

Review 5.  Surgical management of peritonitis secondary to acute superior mesenteric artery occlusion.

Authors:  Stefan Acosta
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 6.  Acute Mesenteric Ischemia: Multidetector CT Findings and Endovascular Management.

Authors:  Shuzo Kanasaki; Akira Furukawa; Kanako Fumoto; Yasuyo Hamanaka; Shinichi Ota; Tomohiro Hirose; Akitoshi Inoue; Takako Shirakawa; Linh Dai Hung Nguyen; Syerikjan Tulyeubai
Journal:  Radiographics       Date:  2018 May-Jun       Impact factor: 5.333

7.  Multidetector CT findings in patients with mesenteric ischaemia following cardiopulmonary bypass surgery.

Authors:  T Barrett; S Upponi; T Benaglia; A D Tasker
Journal:  Br J Radiol       Date:  2013-08-21       Impact factor: 3.039

8.  Biphasic CT with mesenteric CT angiography in the evaluation of acute mesenteric ischemia: initial experience.

Authors:  Iain D C Kirkpatrick; Mervyn A Kroeker; Howard M Greenberg
Journal:  Radiology       Date:  2003-08-27       Impact factor: 11.105

9.  Impact of MDCT with intravenous contrast on the survival in patients with acute superior mesenteric artery occlusion.

Authors:  Maria Wadman; T Block; O Ekberg; I Syk; S Elmståhl; S Acosta
Journal:  Emerg Radiol       Date:  2009-08-06

10.  Endovascular Treatment for Acute Thromboembolic Occlusion of the Superior Mesenteric Artery and the Outcome Comparison between Endovascular and Open Surgical Treatments: A Retrospective Study.

Authors:  Zhao Zhang; Dan Wang; Guoxun Li; Ximo Wang; Yuxiang Wang; Gang Li; Tao Jiang
Journal:  Biomed Res Int       Date:  2017-10-24       Impact factor: 3.411

View more
  1 in total

1.  Role of clinical data and multidetector computed tomography findings in acute superior mesenteric artery embolism.

Authors:  Ju-Shun Yang; Zhen-Yu Xu; Fei-Xiang Chen; Mei-Rong Wang; Ruo-Chen Cong; Xiao-Le Fan; Bo-Sheng He; Wei Xing
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.